Evidence map›Paper›PMID 34830396›Full record

ArticleInternational journal of molecular sciences2021

Diagnosis of Prostate Cancer and Prostatitis Using near Infra-Red Fluorescent AgInSe/ZnS Quantum Dots.

Vuyelwa Ncapayi, Neethu Ninan, Thabang C Lebepe, Sundararajan Parani, Aswathy Ravindran Girija, Richard Bright, Krasimir Vasilev, Rodney Maluleke, Ncediwe Tsolekile, Tetsuya Kodama and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Quantum Dot-Enabled Biosensing for Prostate Cancer Diagnostics.Nanomaterials (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Current applications of nanomaterials in urinary system tumors.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Vuyelwa NcapayiDepartment of Chemical Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.
Neethu NinanAcademic Unit of STEM, University of South Australia, Mawson Lakes, SA 5095, Australia.ORCID 0000-0002-4469-5954
Thabang C LebepeDepartment of Chemical Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.ORCID 0000-0002-6623-8519
Sundararajan ParaniDepartment of Chemical Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.ORCID 0000-0001-6107-030X
Aswathy Ravindran GirijaFuture Industries Institute, University of South Australia, Mawson Lakes, SA 5095, Australia.
Richard BrightAcademic Unit of STEM, University of South Australia, Mawson Lakes, SA 5095, Australia.ORCID 0000-0003-1988-0725
Krasimir VasilevAcademic Unit of STEM, University of South Australia, Mawson Lakes, SA 5095, Australia.ORCID 0000-0003-3534-4754
Rodney MalulekeDepartment of Chemical Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.
Ncediwe TsolekileDepartment of Chemical Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.
Tetsuya KodamaDepartment of Biomedical Engineering, Graduate School of Biomedical Engineering, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.ORCID 0000-0003-4727-9558
Oluwatobi S OluwafemiDepartment of Chemical Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.ORCID 0000-0001-8964-5646
University of Johannesburg · ZAUniversity of South Australia · AUTohoku University · JP

Funding

National Research Foundation 129290
6 · The paper itself

Abstract

The link between the microbiome and cancer has led researchers to search for a potential probe for intracellular targeting of bacteria and cancer. Herein, we developed near infrared-emitting ternary AgInSe/ZnS quantum dots (QDs) for dual bacterial and cancer imaging. Briefly, water-soluble AgInSe/ZnS QDs were synthesized in a commercial kitchen pressure cooker. The as-synthesized QDs exhibited a spherical shape with a particle diameter of 4.5 ± 0.5 nm, and they were brightly fluorescent with a photoluminescence maximum at 705 nm. The QDs showed low toxicity against mouse mammary carcinoma (FM3A-Luc), mouse colon carcinoma (C26), malignant fibrous histiocytoma-like (KM-Luc/GFP) and prostate cancer cells, a greater number of accumulations in

Indexed as

AnimalsCell Line, TumorColonic NeoplasmsHistiocytoma, Malignant FibrousHumansIndiumMaleMammary Neoplasms, AnimalMiceProstatic NeoplasmsProstatitisQuantum DotsSeleniumSilverStaphylococcus aureusSulfidesIndiumSeleniumSilverSulfidesWaterZinc Compoundszinc sulfidebioimagingGram-negative bacteriaGram-positive bacterianear infra-red quantum dotsprostate cancer

Identifiers

PMID34830396
PMCPMC8619584
OpenAlexW3216789527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.